ID   KT-1/A3
AC   CVCL_JH29
SY   A3
DR   Wikidata; Q54900520
RX   PubMed=11111114;
RX   PubMed=11506301;
RX   PubMed=12351404;
CC   Population: Japanese.
CC   Characteristics: Interferon-alpha sensitive.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 8
//
RX   PubMed=11111114; DOI=10.1159/000041061;
RA   Yamauchi H., Sakai I., Narumi H., Soga S., Fujita S.;
RT   "Sensitivity to interferon-alpha and interferon-stimulated gene factor
RT   3 binding activity in human chronic myelogenous leukemia cell line
RT   KT-1.";
RL   Acta Haematol. 104:1-9(2000).
//
RX   PubMed=11506301; DOI=10.2169/internalmedicine.40.607;
RA   Yamauchi H., Sakai I., Narumi H., Takeuchi K., Soga S., Fujita S.;
RT   "Development of interferon-alpha resistant subline from human chronic
RT   myelogenous leukemia cell line KT-1.";
RL   Intern. Med. 40:607-612(2001).
//
RX   PubMed=12351404; DOI=10.1182/blood-2002-01-0073;
RA   Sakai I., Takeuchi K., Yamauchi H., Narumi H., Fujita S.;
RT   "Constitutive expression of SOCS3 confers resistance to IFN-alpha in
RT   chronic myelogenous leukemia cells.";
RL   Blood 100:2926-2931(2002).
//